Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Predicting Death Risk in Patients with Severe Hand, Foot and Mouth Disease

References

• Kushner D, Caldwell BD. Hand-foot-and-mouth disease. J Am Podiatr Med Assoc. 1996;86(6):257–259. doi:10.7547/87507315-86-6-257
   PubMed Web of Science ®Google Scholar
• Pathinayake PS, Hsu AC, Wark PA. Innate immunity and immune evasion by enterovirus 71. Viruses. 2015;7(12):6613–6630. doi:10.3390/v7122961
   PubMed Web of Science ®Google Scholar
• Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341(13):936–942. doi:10.1056/NEJM199909233411302
   PubMed Web of Science ®Google Scholar
• Liu SL, Pan H, Liu P, et al. Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. Rev Med Virol. 2015;5(2):115–128. doi:10.1002/rmv.1827
   Web of Science ®Google Scholar
• Chang LY, King CC, Hsu KH, et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in Taiwan. Pediatrics. 2002;109(6):e88. doi:10.1542/peds.109.6.e88
   PubMed Web of Science ®Google Scholar
• Chang PC, Chen SC, Chen KT. The current status of the disease caused by enterovirus 71 infections: epidemiology, pathogenesis, molecular epidemiology, and vaccine development. Int J Environ Res Public Health. 2016;13(9):890. doi:10.3390/ijerph13090890
   PubMed Web of Science ®Google Scholar
• Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systematic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–230. doi:10.1016/j.critrevonc.2013.03.010
   PubMed Web of Science ®Google Scholar
• Arbel Y, Finkelstein A, Halkin A, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012;225(2):456–460. doi:10.1016/j.atherosclerosis.2012.09.009
   PubMed Web of Science ®Google Scholar
• Wang Y, Ju M, Chen C, et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in acute respiratory distress syndrome patients: a retrospective study. J Thorac Dis. 2018;10(1):273–282. doi:10.21037/jtd.2017.12.131
   PubMed Web of Science ®Google Scholar
• Mousa N, Besheer T, Abdel-Razik A, et al. Can combined blood neutrophil to lymphocyte ratio and C-reactive protein be used for diagnosis of spontaneous bacterial peritonitis? Br J Biomed Sci. 2018;75(2):71–75. doi:10.1080/09674845.2017.1396706
   PubMed Web of Science ®Google Scholar
• Ozmen S, Timur O, Calik I, et al. Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) may be superior to C-reactive protein (CRP) for predicting the occurrence of differentiated thyroid cancer. Endocr Regul. 2017;51(3):131–136. doi:10.1515/enr-2017-0013
   PubMedGoogle Scholar
• Hamiel U, Bahat H, Kozer E, Hamiel Y, Ziv-Baran T, Goldman M. Diagnostic markers of acute infections in infants aged 1 week to 3 months: a retrospective cohort study. BMJ Open. 2018;8(1):e018092. doi:10.1136/bmjopen-2017-018092
   PubMed Web of Science ®Google Scholar
• Bekdas M, Goksugur SB, Sarac EG, Erkocoglu M, Demircioglu F. Neutrophil/lymphocyte and C-reactive protein/mean platelet volume ratios in differentiating between viral and bacterial pneumonias and diagnosing early complications in children. Saudi Med J. 2014;35(5):442–447.
   PubMed Web of Science ®Google Scholar
• Yazici M, Ozkisacik S, Oztan MO, Gürsoy H. Neutrophil/lymphocyte ratio in the diagnosis of childhood appendicitis. Turk J Pediatr. 2010;52(4):400–403.
   PubMed Web of Science ®Google Scholar
• Ministry of Health of the People’s Republic of China. Hand, foot and mouth disease clinic guide (2010 edition). (in Chinese). Available from: http://www.nhc.gov.cn/xxgk/pages/viewdocument.jsp?dispatchDate=&staticUrl=/zwgkzt/wsbysj/201004/46884.shtml. Accessed October 11, 2020.
   Google Scholar
• Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012;5(1):2. doi:10.1186/1755-7682-5-2
   PubMedGoogle Scholar
• Dolan RD, Lim J, McSorley ST, Horgan PG, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis. Sci Rep. 2017;7(1):16717.
   PubMed Web of Science ®Google Scholar
• Motomura T, Shirabe K, Mano Y, et al. Neutrophil-lymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol. 2013;58(1):58–64.
   PubMed Web of Science ®Google Scholar
• Gao SQ, Huang LD, Dai RJ, Chen DD, Hu WJ, Shan YF. Neutrophil-lymphocyte ratio: a controversial marker in predicting Crohn’s disease severity. Int J Clin Exp Pathol. 2015;8(11):14779–14785.
   PubMed Web of Science ®Google Scholar
• Lee JW, Park JS, Park KB, Yoo GH, Kim SS, Lee SM. Prediction of renal cortical defect and scar using neutrophil-to-lymphocyte ratio in children with febrile urinary tract infection. Nuklearmedizin. 2017;56(3):109–114. doi:10.3413/Nukmed-0878-17-01
   PubMedGoogle Scholar
• Zhou Y-Q, Feng D-Y, Li W-J, et al. Lower neutrophil-to-lymphocyte ratio predicts high risk of multidrug-resistant Pseudomonas aeruginosa infection in patients with hospital-acquired pneumonia. Ther Clin Risk Manag. 2018;14:1863–1869. doi:10.2147/TCRM.S179181
   PubMed Web of Science ®Google Scholar
• Shang WZ, Qian SY, Fang LJ, Han Y, Zheng CP. Association study of inflammatory cytokine and chemokine expression in hand foot and mouth disease. Oncotarget. 2017;8(45):79425–79432. doi:10.18632/oncotarget.18341
   PubMedGoogle Scholar
• Wesche DE, Lomas-Neira JL, Perl M, Chung CS, Ayala A. Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol. 2005;78(2):325–337. doi:10.1189/jlb.0105017
   PubMed Web of Science ®Google Scholar
• Li J, Chen Q, Luo X, et al. Neutrophil-to-lymphocyte ratio positively correlates to age in healthy population. J Clin Lab Anal. 2015;29(6):437–443. doi:10.1002/jcla.21791
   PubMed Web of Science ®Google Scholar
• Gürol G, Çiftci İH, Terizi HA, Atasoy AR, Ozbek A, Köroğlu M. Are there standardized cutoff values for neutrophil-lymphocyte ratios in bacteremia or sepsis? J Microbiol Biotechnol. 2015;25(4):521–525. doi:10.4014/jmb.1408.08060
   PubMed Web of Science ®Google Scholar
• Long L, Gao LD, Hu SX, et al. Risk factors for death in children with severe hand, foot, and mouth disease in Hunan, China. Infect Dis (Lond). 2016;48(10):44–748.
   Web of Science ®Google Scholar
• Qiu J, Yan H, Cheng N, et al. The clinical and epidemiological study of children with hand, foot, and mouth disease in Hunan, China from 2013 to 2017. Sci Rep. 2019;9:11662. doi:10.1038/s41598-019-48259-1
   PubMed Web of Science ®Google Scholar
• Qiu J. Enterovirus 71 infection: a new threat to global public health? Lancet Neurol. 2008;7(10):868–869. doi:10.1016/S1474-4422(08)70207-2
   PubMed Web of Science ®Google Scholar
• Lee KY. Enterovirus 71 infection and neurological complications. Korean J Pediatr. 2016;59(10):395–401. doi:10.3345/kjp.2016.59.10.395
   PubMedGoogle Scholar
• Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, Phase 3 trial. Lancet. 2013;381(9882):2024–2032. doi:10.1016/S0140-6736(13)61049-1
   PubMed Web of Science ®Google Scholar
• Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014;370(9):818–828. doi:10.1056/NEJMoa1304923
   PubMed Web of Science ®Google Scholar
• Mao QY, Wang Y, Bian L, Xu M, Liang Z. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease (HFMD). Expert Rev Vaccines. 2016;15(5):599–606. doi:10.1586/14760584.2016.1138862
   PubMed Web of Science ®Google Scholar
• Tambyah PA, Oon J, Asli R, et al. An inactivated enterovirus 71 vaccine is safe and immunogenic in healthy adults: A Phase I, double blind, randomized, placebo-controlled, study of two dosages. Vaccine. 2019;37(31):4344–4353. doi:10.1016/j.vaccine.2019.06.023
   PubMed Web of Science ®Google Scholar
• Liu D, Leung K, Jit M, et al. Cost-effectiveness of bivalent versus monovalent vaccines against hand, foot and mouth disease. Clin Microbiol Infect. 2020;26(3):373–380. doi:10.1016/j.cmi.2019.06.029
   PubMed Web of Science ®Google Scholar
• Esposito S, Principi N. Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. Eur J Clin Microbiol Infect Dis. 2018;37(3):391–398. doi:10.1007/s10096-018-3206-x
   PubMed Web of Science ®Google Scholar